Search
for
Sort by
Research 15
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Janus Kinase inhibitors in dermatology: a review
- The role of janus kinases in the treatment of autoimmune skin diseases
- Treatment of severe alopecia areata with baricitinib
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- The JAK/STAT signaling pathway: from bench to clinic
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Under Development JAK Inhibitors for Dermatologic Diseases
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata